By Kathryn Calkins
Staff Writer

With a growing stable of young oncology products, the possibility that Genentech Inc. might partner its thrombopoietin protein probably wasn't at the top of any list of moves that an outsider would expect from the company. But by signing a worldwide marketing deal for the platelet booster with Pharmacia & Upjohn Inc., GNE last week said it was meeting two objectives.